about
Reduced drug incorporation into DNA and antiapoptosis as the crucial mechanisms of resistance in a novel nelarabine-resistant cell line.Nucleic Acid Bioconjugates in Cancer Detection and Therapy.HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous LeukemiaSapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaksTargeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations.Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Sapacitabine for cancer
@ast
Sapacitabine for cancer
@en
Sapacitabine for cancer
@nl
type
label
Sapacitabine for cancer
@ast
Sapacitabine for cancer
@en
Sapacitabine for cancer
@nl
prefLabel
Sapacitabine for cancer
@ast
Sapacitabine for cancer
@en
Sapacitabine for cancer
@nl
P2860
P1476
Sapacitabine for cancer
@en
P2093
Xiaojun Liu
P2860
P304
P356
10.1517/13543784.2012.660249
P407
P577
2012-04-01T00:00:00Z